Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System Lymphoma (PCNSL)[E1F05]

被引：0
|
作者：
Swinnen, Lode J. [1 ]
O'Neill, Anne [2 ]
Imus, Philip H. [1 ]
Gujar, Sachin [3 ]
Schiff, David [4 ]
Kleinberg, Lawrence [5 ]
Advani, Ranjana [6 ]
Dunbar, Erin [7 ]
Moore, Dennis F., Jr. [8 ]
Grossman, Stuart [1 ]
机构：
[1] Johns Hopkins, Med Oncol, Baltimore, MD USA
[2] Dana Farber Harvard Canc Ctr, BIostat Core, Cambridge, MA USA
[3] Johns Hopkins, Dept Radiol, Baltimore, MD USA
[4] Univ Virginia, Charlottesville, VA USA
[5] Johns Hopkins, Radiat Oncol, Baltimore, MD USA
[6] Stanford Canc Ctr, Stanford, CA USA
[7] Univ Florida, Gainesville, FL USA
[8] Wichita CCOP, Canc Ctr Kansas, Wichita, KS USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy: Final report
    Juergens, A.
    Pels, H.
    Glasmacher, A.
    Schulz, H.
    Fliessbach, K.
    Linnebank, M.
    Vogt-Schaden, M.
    Reichmann, H.
    Schmidt-Wolf, I. G. H.
    Schlegel, U.
    NEURO-ONCOLOGY, 2006, 8 (04) : 357 - 357
  • [42] Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy - Final report
    Juergens, A.
    Pels, H.
    Schlegel, U.
    Schmidt-Wolf, I. G. H.
    Glasmacher, A.
    Schulz, H.
    Engert, A.
    Diehl, V.
    Schackert, G.
    Reichmann, H.
    Kroschinsky, F.
    Vogt-Schaden, M.
    Egerer, G.
    Bode, U.
    Schaller, C.
    Deckert, M.
    Fimmers, R.
    Fliessbach, K.
    Klockgether, T.
    Zellner, A.
    JOURNAL OF NEUROLOGY, 2006, 253 : 23 - 24
  • [43] Intensive chemotherapy-followed by hematopoietic stem cell rescue for refractory or recurrent primary central nervous system (PCNSL) or intra ocular lymphoma (IOL). Results of a multicentric phase II study.
    Soussain, Carole
    Hoang-Xuan, Khe
    Taillandier, Luc
    Casasnovas, Olivier
    Dupriez, Brigitte
    Taksin, Anne-Laure
    Souleau, Bertrand
    Kolb, Brigitte
    Jaccard, Arnaud
    Zini, Jean-Marc
    Choquet, Sylvain
    Witz, Francis
    Janvier, Maud
    Leblond, Veronique
    BLOOD, 2006, 108 (11) : 123A - 123A
  • [44] Phase Ib/II Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab and Lenalidomide in Refractory/Recurrent Primary (PCNSL) and Secondary Central Nervous System Lymphoma (SCNSL)
    Grommes, Christian
    Piotrowski, Anna
    Pentsova, Elena
    Gavrilovic, Igor
    Stone, Jacqueline B.
    Lin, Andrew
    Wongchai, Venissala
    Madzsar, Juli T.
    Malani, Rachna
    Nolan, Craig
    Francis, Jasmine
    DeAngelis, Lisa
    Schaff, Lauren
    Mellinghoff, Ingo K.
    BLOOD, 2022, 140 : 3807 - 3808
  • [45] RETROSPECTIVE STUDY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): IMPACT OF TREATMENT STRATEGIES OF THE LAST 20 YEARS
    Iskanderani, Omar
    Izar, Francoise
    Benouaich-Amiel, Alexandra
    Filleron, Thomas
    Moyal, Elisabeth
    NEURO-ONCOLOGY, 2013, 15 : 78 - 78
  • [46] CHEMOTHERAPY WITHOUT RADIATION-THERAPY AS INITIAL TREATMENT FOR PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL) IN OLDER PATIENTS
    FREILICH, RJ
    DELATTRE, JY
    SARAZIN, M
    DEANGELIS, LM
    NEUROLOGY, 1995, 45 (04) : A451 - A451
  • [47] A prospective study on the circulation and central nervous system after primary central nervous system B cell lymphoma treatment with rituximab.
    Lin, Tongyu
    Peng, Chen
    Liu, Shu
    Guo, Cheng-cheng
    Wang, Zhao
    Huang, He
    Fang, Xiaojie
    Hong, Huang Ming
    Ren, Quanguang
    Li, Fangfang
    Li, Xue Ying
    Tian, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
    Sun, Xuefei
    Liu, Jing
    Wang, Yaming
    Bai, Xueyan
    Chen, Yuedan
    Qian, Jun
    Zhu, Hong
    Liu, Fusheng
    Qiu, Xiaoguang
    Sun, Shengjun
    Ji, Nan
    Liu, Yuanbo
    ONCOTARGET, 2017, 8 (30) : 49156 - 49164
  • [49] Methotrexate-Cytarabine-Dexamethasone Combination Chemotherapy with or without Rituximab in Patients with Primary Central Nervous System Lymphoma
    Liu, Jing
    Sun, Xuefei
    Bai, Xueyan
    Chen, Yuedan
    Qian, Jun
    Zhu, Hong
    Wang, Yaming
    Ji, Nan
    Sun, Shengjun
    Wang, Yajie
    Liu, Yuanbo
    BLOOD, 2016, 128 (22)
  • [50] High-dose methotrexate (HD-MTX) neoadjuvant chemotherapy for primary central nervous system lymphoma (PCNSL) in elderly patients
    Zhu, J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 455 - 455
12345